SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

  • This share is currently suspended. It was suspended at a price of 0.125
  • There is currently no data for CRV

Update on Investment

21 Nov 2013 11:15

RNS Number : 6271T
Craven House Capital PLC
21 November 2013
 



21 November 2013

 

Craven House Capital Plc

("Craven House" or the "Company")

 

Update on Investment

 

Craven House today announces that it has completed the restructuring of the distressed loan that it acquired in May 2013 (the "Loan"), as previously announced on 28 May 2013.

 

The Loan, which was secured over the Green Isle Conference and Leisure Hotel in Dublin (the "Hotel"), was acquired by Craven House for €0.7 million, with Craven House becoming the sole secured lender for the Hotel. Craven House directors believed that with the right capital structure the Hotel could form an attractive asset. The Company has now restructured the Loan, facilitating the simultaneous sale of the Hotel to new owners. Under the restructuring, Craven House has agreed with the new owners to convert the Loan into a new mortgage of €1.5 million (the "Mortgage"). The Mortgage will carry an interest rate of 4% per annum and will be repaid in full within three years.

 

As previously announced, Craven House borrowed €0.7 million from Desmond Holdings Ltd, the Company's investment manager, in order to acquire the Loan. As a precondition of converting the Loan into the Mortgage and releasing the original security over the hotel, Craven House received sufficient funds from the Hotel to fully repay the original €0.7m borrowed from Desmond Holdings

 

The restructuring of the Loan into the Mortgage and the repayment to Desmond Holdings have resulted in an increase of €1.5 million in the net asset value of Craven House, as well as providing annual interest payments of £60,000 for the next three years.

 

Mark Pajak, Acting Chairman, commented, "This has proved to be an outstanding result for Craven House. In a period of less than six months we have repaid, in full, the €700,000 loan we took out to acquire the asset and have now restructured the mortgage, making the hotel a viable and attractive going concern for the new owners. This transaction has achieved two of our stated goals; firstly our aim to acquire a cash-generative asset (interest payments under the Mortgage are £60,000 per annum) and secondly it has increased Craven House Capital's net asset value by €1,500,000; which further underlines our firm belief that the Company's shares continue to trade at a discount to the underlying value of our assets. We are in active dialogue regarding similar, distressed loans and assets and we look forward to replicating this type of transaction in the future. "

 

 

For further information please contact:

 

Craven House Capital Plc:

 

www.cravenhousecapital.com

 

 

Alexandra Eavis

Non Executive Director & Company Secretary

 

Tel: 07590 831 323

 

 

Daniel Stewart & Company Plc:

(Nominated Adviser & Broker)

 

Antony Legge/James Thomas

Tel: 020 7776 6550

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBBBBTMBBTBBJ
Date   Source Headline
24th Jul 20257:00 amRNSCancellation - Craven House Capital PLC
23rd Jun 202510:30 amRNSWithdrawl of 'Stmt re Share Price Movement' RNS
23rd Jun 202510:05 amRNSStatement re Share Price Movement
23rd Jun 20257:30 amRNSSuspension - Craven House Capital Plc
23rd Jun 20257:00 amRNSResignation of Nominated Adviser
27th Feb 20257:00 amRNSInterim Results
7th Feb 20254:22 pmRNSTR-1: Notification of major holdings
16th Dec 20242:42 pmRNSResult of AGM
15th Nov 20247:00 amRNSAnnual Results For Year Ended 31 May 2024
10th Sep 20247:00 amRNSInvestee company update: RoseMonkey Ltd
27th Aug 20247:00 amRNSTR-1: Notification of major holdings
23rd Aug 20242:19 pmRNSTR-1: notification of major holdings
5th Jun 20247:00 amRNSInvestee Companies' Update: Bio Vitos
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.